Memo_Key To Bundled Pkg_0925-0589-6,7,8

Date: November 29, 2010

To: Office of Management and Budget (OMB)

Through: Seleda Perryman, DHHS Report Clearance Officer

Mikia Currie, Program Analyst, NIH Project Clearance Branch, OPERA

From: Vivian Horovitch-Kelley, NCI OMB Project Clearance Liaison,

Office of Management Analysis and Assessment (OMAA)

National Cancer Institute/NIH

Subject: Bundled Generic Sub-Study Packages for 0925-0589, #6, #7, and #8

The National Cancer Institute is proposing three generic sub-studies (bundled) under OMB #: 0925-0589 due to the length of time it would take to clear three separate sub-studies.

The first sub-study involves focus groups to test preliminary materials in preparation for the full information collection of Health Information National Trends Survey (HINTS) in 2011. The second sub-study involves cognitive interviews for finalizing the Multidisciplinary (MDC) Survey for administration by the Commission on Cancer. The third sub-study is a website evaluation of the NCI Experimental Therapeutics (NExT) website (http://next.cancer.gov).

The file “#6 #7 #8 Bundled Gen IC” (i.e., Generic IC Forms) highlight the abstracts for each proposed project and is included in this submission.

The key to understanding the attachments and files in ICRAS/ROCIS is as listed below.

Sub-study #6:

Full title: “Health Information National Trends Survey (HINTS) 4 Advance Materials Focus Groups”

Abbreviated Title: HINTS

Attachments are labeled “6” and include:

• Justification Memo and Attachments 6B (Reminder Letter), 6C (Test Materials), 6E (Consent Form), and 6F (Westat IRB Approval)

• Attachments 6A (Screener) and 6D (Moderator Guide)

Sub-study #7:

Full title: “Cognitive Testing for Multidisciplinary Care (MDC) Survey”

Abbreviated Title: MDC

Attachments are labeled “7” and include:

• Justification Memo and Attachments 7B (Cover Letter), 7D (Consent) and 7F (IRB Approval)

• Attachments 7A (Scheduling Script), 7C (Survey) and 7D (Moderator’s Guide)

Sub-study #8:

Full title: “Evaluation of the NCI Experimental Therapeutics (NExT) Website”

Abbreviated Title: NExT

Attachments are labeled “8” and include:

• Justification Memo and Attachments 8B (Consent), 8C (Script for Verbal Consent), 8D (Timeline) and 8H (OHSR Request)

• Attachments 8A (Recruiting Email/Screener), 8E (Facilitator’s Guide), 8F (System Usability Scale), and 8G (Modified Cooper-Harper Difficulty Rating Scale)

Notes to OMB: The affected public is different for all three studies. For sub-study #6, the affected respondents are “Individuals.” For sub-study #7 and #8, the affected public will include “Individuals”, as well as “Private Sector” (Business and Not-for-Profit) and “Federal Government.” Additionally, the total requested responses and burden was calculated by taking the sum for the three sub-studies (see combined tables below).

Types of Respondents	Instrument	Number of Respondents	Frequency of Response	Time per Response (Min/Hours)	Annual Burden Hours
General Public (Sub-Study #6)	Screening Questionnaire (Attach 6A)	80	1	5/60 (0.083)	7
	Focus Group/Moderator Guide (Attach 6C and 6D)	40	1	90/60 (1.5)	60
Physicians and Administrators (Sub-Study #7)	Scheduling Script (Attach 7A)	18	1	10/60 (0.17)	3
	Blank Questionnaire and Cognitive Interview (Attach 7C and 7D)	18	1	90/60 (1.5 hours)	27
Research Scientists (Sub-Study #8)	Responding to email (Attach 8A)	27	1	10/60 (0.167)	5
	Interview and Usability Testing (Attach 8E)	27	1	50/60 (0.833)	23
	System Usability Scale (Attach 8F)	27	1	5/60 (0.083)	2
	Cooper Harper Scale (Attach 8G)	27	1	5/60 (0.083)	2
Total		264			129

2